Peer Review History: Assessing the Specificity of Paclitaxel towards the Marker Proteins of Breast Cancer Using In silico Molecular Docking Study

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.45/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Mircea Tampa, Romania) | File 1 | NA

Stage 2 | Peer review report_2 (Bui Thanh Tung, Vietnam) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA